Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - gonadotrophinum chorionicum - polvere e solvente per soluzione iniettabile (siringa preriempita con solvente) - praeparatio cryodesiccata: gonadotrophinum chorionicum 500 u.i. hcg, lactosum monohydricum, pro vitro. solvens: natrii chloridum corresp. natrium 3.54 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - amenorrea, anovulazione; criptorchidismo, ipogonadismo ipogonadotropinico, pubertas tarda.; stimolazione follicolare nella riproduzione medicalmente assistita. - biotechnologika

Unione Europea - italiano - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Unione Europea - italiano - EMA (European Medicines Agency)

n.v. organon - ganirelix - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - la prevenzione dei picchi di ormone luteinizzante prematuri in donne sottoposte a iperstimolazione ovarica per tecniche di riproduzione assistita controllata. negli studi clinici, orgalutran è stato utilizzato con ricombinante umano ormone follicolo-stimolante o corifollitropin alfa, sostenuta follicolo stimolante.

Unione Europea - italiano - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - neoplasie prostatiche - terapia endocrina - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Unione Europea - italiano - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - leiomioma - ormoni ipofisari e ipotalamici e analoghi - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Italia - italiano - Ministero della Salute

laboratorios calier s.a. - lhp, soluzione fisiologica sterile, fsh ipofisario suino - lhp - 500 ui; soluzione fisiologica sterile - nd ; fsh ipofisario suino - 500 ui, fsh ipofisario suino - 500 ui; soluzione fisiologica sterile - nd ; lhp - 500 ui - gonadotropins

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bayer s.p.a. - mesterolone - mesterolone

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ferring s.p.a. - triptorelina - triptorelina